HERON THERAPEUTICS

heron-therapeutics-logo

Heron Therapeutics Inc, formerly A.P. Pharma, Inc. is a specialty pharmaceutical company developing pharmaceutical products using its Biochronomer polymer-based drug delivery platform. The Company’s lead product candidate, APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting (CINV) for patients undergoing both moderately and highly emetogenic chemotherapy and for the prevention of delayed CINV for patients undergoing moderately emetogenic chemotherapy. APF530 contains the 5-HT3 antagonist granisetron formulated in the Company’s Biochronomer drug delivery system, which allows therapeutic drug levels to be maintained for five days with a single subcutaneous injection.
#SimilarOrganizations #People #Financial #Event #Website #More

HERON THERAPEUTICS

Industry:
Biotechnology Health Care Therapeutics

Founded:
1987-01-01

Address:
Redwood City, California, United States

Country:
United States

Website Url:
http://www.herontx.com

Total Employee:
101+

Status:
Active

Contact:
800-962-4284

Email Addresses:
[email protected]

Total Funding:
450.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Content Delivery Network Wordpress Plugins Nginx


Similar Organizations

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

Current Employees Featured

not_available_image

Lisa Peraza
Lisa Peraza Vice President, Chief Accounting Officer @ Heron Therapeutics
Vice President, Chief Accounting Officer
2020-10-01

chris-storgard_image

Chris Storgard
Chris Storgard Chief Medical Officer @ Heron Therapeutics
Chief Medical Officer
2019-12-01

barry-quart_image

Barry Quart
Barry Quart Founder, CEO & Director @ Heron Therapeutics
Founder, CEO & Director
2014-01-01

john-poyhonen_image

John Poyhonen
John Poyhonen President & Chief Commercial Officer @ Heron Therapeutics
President & Chief Commercial Officer
2019-07-01

mark-s-gelder_image

Mark S. Gelder
Mark S. Gelder SVP & CMO @ Heron Therapeutics
SVP & CMO
2014-01-01

tom-ottoboni_image

Tom Ottoboni
Tom Ottoboni Chief Scientific Officer and Senior VP, Pharmaceutical and Translational Sciences @ Heron Therapeutics
Chief Scientific Officer and Senior VP, Pharmaceutical and Translational Sciences
2011-01-01

david-szekeres_image

David Szekeres
David Szekeres EVP, Chief Operating Officer @ Heron Therapeutics
EVP, Chief Operating Officer
2016-03-01

Founder


barry-quart_image

Barry Quart

Stock Details


Company's stock symbol is NASDAQ:HRTX

Investors List

deep-track-capital_image

Deep Track Capital

Deep Track Capital investment in Post-IPO Equity - Heron Therapeutics

broadfin_image

Broadfin Capital

Broadfin Capital investment in Post-IPO Equity - Heron Therapeutics

great-point-partners_image

Great Point Partners

Great Point Partners investment in Post-IPO Equity - Heron Therapeutics

tang-capital-management_image

Tang Capital Management

Tang Capital Management investment in Post-IPO Equity - Heron Therapeutics

Newest Events participated

beckers-asc-26th-annual-meeting_event_image Participated in Becker’s ASC 26th Annual Meeting on 2019-10-24 as exhibitor

beckers-asc-26th-annual-meeting_event_image Participated in Becker’s ASC 26th Annual Meeting on 2019-10-24 as sponsor

Official Site Inspections

http://www.herontx.com Semrush global rank: 1.66 M Semrush visits lastest month: 14.88 K

  • Host name: 52.57.237.35.bc.googleusercontent.com
  • IP address: 35.237.57.52
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Heron Therapeutics" on Search Engine

dfkcompany.com © 2022. All rights reserved